FoxLogica

πŸ“‰ EFUL: SELL Signal (6/10) – Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations

⚑ Flash Summary

On October 31st, 2025, EFU Life Assurance Ltd. disclosed a transaction by Saifuddin N. Zoomkawala, a Non-Executive Director, under PSX Regulation 5.6.4. The director sold 10,000 shares at a rate of PKR 151.16 per share on October 30, 2025. Following this transaction, Zoomkawala’s cumulative shareholding stands at 474,617 shares, representing 0.45% of the company. The shares were sold in the β€˜Ready’ market through CDC certificates. This disclosure ensures transparency regarding the dealings of company insiders.

Signal: SELL πŸ“‰
Strength: 6/10
Sentiment: NEGATIVE
Time Horizon: MEDIUM_TERM

πŸ“Œ Key Takeaways

  • πŸ“… Transaction Date: October 30, 2025.
  • πŸ‘€ Person Involved: Saifuddin N. Zoomkawala, Non-Executive Director.
  • πŸ’Ό Nature of Transaction: Sale of shares.
  • πŸ“‰ Number of Shares Sold: 10,000 shares.
  • πŸ’² Rate per Share: PKR 151.16.
  • πŸ“Š Market: Ready market.
  • πŸ“œ Form of Shares: CDC Certificates.
  • holding after transaction: 474,617 shares.
  • πŸ“‰ Percentage Holding: 0.45% of the company.
  • regulatory compliance: transaction disclosed under PSX Regulation 5.6.4.
  • ℹ️ Disclosure Requirement: Company Secretary to present transaction at the next Board meeting.
  • ⏳ Holding Period Rule: Transactions must comply with the holding period rules of over six months.
  • 🚫 Restriction: No dealing in shares during closed periods by Directors/CEOs/Executives.
  • portal updates: Company to update details in the UIN Management System.

🎯 Investment Thesis

HOLD. While the insider selling is a slightly negative signal, the amount is small and does not warrant a strong sell recommendation. Further monitoring of insider transactions and company performance is advisable. A price target cannot be accurately determined without more information or financial data in this disclosure.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Exit mobile version